Impact of direct acting antiviral (DAA) treatment on glucose metabolism and reduction of pre-diabetes in patients with chronic hepatitis C
BACKGROUND AND AIM: With the development of direct acting antiviral agents (DAA) chronic hepatitis C virus (HCV) infection has become curable in most patients. Since HCV infection is known to have direct and/or indirect effects on glucose metabolism, successful HCV treatment may have an impact in re...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2018
|
| In: |
Journal of gastrointestinal and liver diseases
Year: 2018, Jahrgang: 27, Heft: 3, Pages: 281-289 |
| ISSN: | 1842-1121 |
| Online-Zugang: |
|
| Verfasserangaben: | Philip Weidner, Dominik Boettche, Thomas Zimmerer, Elke Burgermeister, Andreas Teufel, Matthias P.A. Ebert, Christoph Antoni |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1668436124 | ||
| 003 | DE-627 | ||
| 005 | 20230427152726.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190703s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.15403/jgld.2014.1121.273.daa |2 doi | |
| 035 | |a (DE-627)1668436124 | ||
| 035 | |a (DE-599)KXP1668436124 | ||
| 035 | |a (OCoLC)1341231965 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Weidner, Philip |d 1987- |e VerfasserIn |0 (DE-588)1151598216 |0 (DE-627)101194216X |0 (DE-576)497900327 |4 aut | |
| 245 | 1 | 0 | |a Impact of direct acting antiviral (DAA) treatment on glucose metabolism and reduction of pre-diabetes in patients with chronic hepatitis C |c Philip Weidner, Dominik Boettche, Thomas Zimmerer, Elke Burgermeister, Andreas Teufel, Matthias P.A. Ebert, Christoph Antoni |
| 264 | 1 | |c 2018 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 03.07.2019 | ||
| 520 | |a BACKGROUND AND AIM: With the development of direct acting antiviral agents (DAA) chronic hepatitis C virus (HCV) infection has become curable in most patients. Since HCV infection is known to have direct and/or indirect effects on glucose metabolism, successful HCV treatment may have an impact in reducing glucose level, pre-diabetes, the need of treatment for diabetes, and ultimately diabetes-associated morbidity. We investigated the association of DAA treatment and glucose metabolism in the context of development or resolution of hepatic fibrosis in a large cohort of HCV- infected patients. - METHODS: In this retrospective single-center observational study, we investigated 281 patients receiving all-oral DAA therapy for fasting plasma glucose, HbA1c, liver enzymes and general clinical chemistry, measured during a 52-week follow-up. In addition, elastography, FIB-4- and APRI-calculation were used to assess hepatic fibrosis non-invasively. - RESULTS: Successful elimination of HCV through DAA treatment was associated with a significant drop in fasting glucose level and a reduced rate of impaired fasting plasma glucose (FPG). Interestingly, this metabolic change was BMI-independent. In addition, long-term glucose levels also decreased after successful DAA treatment. A significant APRI-score reduction was associated with a persistent improvement of FPG. However, DAA did not have an impact on glucose metabolism in patients suffering from liver cirrhosis. - CONCLUSION: This study highlights the beneficial impact of successful HCV therapy on glucose metabolism and identifies patients with liver cirrhosis as a collective in need of intensified surveillance with regard to diabetes progression despite HCV eradication. | ||
| 650 | 4 | |a Antiviral Agents | |
| 650 | 4 | |a Biomarkers | |
| 650 | 4 | |a Blood Glucose | |
| 650 | 4 | |a Drug Therapy, Combination | |
| 650 | 4 | |a Female | |
| 650 | 4 | |a Germany | |
| 650 | 4 | |a Glycated Hemoglobin A | |
| 650 | 4 | |a Hepatitis C, Chronic | |
| 650 | 4 | |a Humans | |
| 650 | 4 | |a Liver | |
| 650 | 4 | |a Liver Cirrhosis | |
| 650 | 4 | |a Male | |
| 650 | 4 | |a Middle Aged | |
| 650 | 4 | |a Prediabetic State | |
| 650 | 4 | |a Retrospective Studies | |
| 650 | 4 | |a Risk Factors | |
| 650 | 4 | |a Time Factors | |
| 650 | 4 | |a Treatment Outcome | |
| 700 | 1 | |a Böttche, Dominik |e VerfasserIn |0 (DE-588)1189746999 |0 (DE-627)1668439123 |4 aut | |
| 700 | 1 | |a Burgermeister, Elke |d 1968- |e VerfasserIn |0 (DE-588)173413455 |0 (DE-627)704732858 |0 (DE-576)184247551 |4 aut | |
| 700 | 1 | |a Teufel, Andreas |d 1971- |e VerfasserIn |0 (DE-588)121120031 |0 (DE-627)081100035 |0 (DE-576)292546750 |4 aut | |
| 700 | 1 | |a Ebert, Matthias |d 1968- |e VerfasserIn |0 (DE-588)1030133522 |0 (DE-627)734827083 |0 (DE-576)377938432 |4 aut | |
| 700 | 1 | |a Antoni, Christoph Helmer |d 1968- |e VerfasserIn |0 (DE-588)120403269 |0 (DE-627)696641100 |0 (DE-576)292200846 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of gastrointestinal and liver diseases |d Cluj-Napoca : Soc., 2006 |g 27(2018), 3, Seite 281-289 |h Online-Ressource |w (DE-627)518632555 |w (DE-600)2253255-9 |w (DE-576)281384517 |x 1842-1121 |7 nnas |a Impact of direct acting antiviral (DAA) treatment on glucose metabolism and reduction of pre-diabetes in patients with chronic hepatitis C |
| 773 | 1 | 8 | |g volume:27 |g year:2018 |g number:3 |g pages:281-289 |g extent:9 |a Impact of direct acting antiviral (DAA) treatment on glucose metabolism and reduction of pre-diabetes in patients with chronic hepatitis C |
| 951 | |a AR | ||
| 992 | |a 20190703 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 120403269 |a Antoni, Christoph Helmer |m 120403269:Antoni, Christoph Helmer |d 60000 |d 61100 |e 60000PA120403269 |e 61100PA120403269 |k 0/60000/ |k 1/60000/61100/ |p 7 |y j | ||
| 998 | |g 1030133522 |a Ebert, Matthias |m 1030133522:Ebert, Matthias |d 60000 |d 61100 |e 60000PE1030133522 |e 61100PE1030133522 |k 0/60000/ |k 1/60000/61100/ |p 6 | ||
| 998 | |g 121120031 |a Teufel, Andreas |m 121120031:Teufel, Andreas |d 60000 |d 61100 |e 60000PT121120031 |e 61100PT121120031 |k 0/60000/ |k 1/60000/61100/ |p 5 | ||
| 998 | |g 173413455 |a Burgermeister, Elke |m 173413455:Burgermeister, Elke |d 60000 |d 61100 |e 60000PB173413455 |e 61100PB173413455 |k 0/60000/ |k 1/60000/61100/ |p 4 | ||
| 998 | |g 1189746999 |a Böttche, Dominik |m 1189746999:Böttche, Dominik |d 60000 |d 61100 |e 60000PB1189746999 |e 61100PB1189746999 |k 0/60000/ |k 1/60000/61100/ |p 2 | ||
| 998 | |g 1151598216 |a Weidner, Philip |m 1151598216:Weidner, Philip |d 60000 |d 61100 |e 60000PW1151598216 |e 61100PW1151598216 |k 0/60000/ |k 1/60000/61100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1668436124 |e 3490667131 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"title":[{"title_sort":"Journal of gastrointestinal and liver diseases","subtitle":"official journal of the Romanian Societies of Gastroenterology","title":"Journal of gastrointestinal and liver diseases"}],"pubHistory":["15.2006 -"],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 19.10.20"],"type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"volume":"27","pages":"281-289","text":"27(2018), 3, Seite 281-289","extent":"9","year":"2018","issue":"3"},"origin":[{"dateIssuedKey":"2006","publisher":"Soc.","dateIssuedDisp":"2006-","publisherPlace":"Cluj-Napoca"}],"id":{"issn":["1842-1121"],"zdb":["2253255-9"],"eki":["518632555"]},"disp":"Impact of direct acting antiviral (DAA) treatment on glucose metabolism and reduction of pre-diabetes in patients with chronic hepatitis CJournal of gastrointestinal and liver diseases","recId":"518632555"}],"note":["Gesehen am 03.07.2019"],"recId":"1668436124","name":{"displayForm":["Philip Weidner, Dominik Boettche, Thomas Zimmerer, Elke Burgermeister, Andreas Teufel, Matthias P.A. Ebert, Christoph Antoni"]},"origin":[{"dateIssuedDisp":"2018","dateIssuedKey":"2018"}],"id":{"eki":["1668436124"],"doi":["10.15403/jgld.2014.1121.273.daa"]},"language":["eng"],"physDesc":[{"extent":"9 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title_sort":"Impact of direct acting antiviral (DAA) treatment on glucose metabolism and reduction of pre-diabetes in patients with chronic hepatitis C","title":"Impact of direct acting antiviral (DAA) treatment on glucose metabolism and reduction of pre-diabetes in patients with chronic hepatitis C"}],"person":[{"family":"Weidner","given":"Philip","role":"aut","display":"Weidner, Philip"},{"family":"Böttche","role":"aut","given":"Dominik","display":"Böttche, Dominik"},{"role":"aut","given":"Elke","family":"Burgermeister","display":"Burgermeister, Elke"},{"family":"Teufel","role":"aut","given":"Andreas","display":"Teufel, Andreas"},{"display":"Ebert, Matthias","role":"aut","given":"Matthias","family":"Ebert"},{"display":"Antoni, Christoph Helmer","given":"Christoph Helmer","role":"aut","family":"Antoni"}]} | ||
| SRT | |a WEIDNERPHIIMPACTOFDI2018 | ||